(Q55485571)

English

Treatment of glioma with intratumoral instillation of autologous lymphocytes.

scientific article published in February 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

Treatment of glioma with intratumoral instillation of autologous lymphocytes. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

author name string

S N Bhagwati

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

publication date

1 February 1989

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

Child's Nervous System

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

5

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

1

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

38-40

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

https://scigraph.springernature.com/pub.10.1007/bf00706746

0 references

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-Mediated Immunity to Tumor Cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell-mediated immunity and blocking factors in patients with tumours of the central nervous system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serological analysis of cell surface antigens of malignant human brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms by which human gliomas may escape cellular immune attack

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific cellular immune responses in patients with malignant gliomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunological aspects of intrinsic glial tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunobiology of primary intracranial tumors. Part 3: Microcytotoxicity assays of specific immune responses of brain tumor patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2 and autologous lymphokine-activated killer cells in the treatment of malignant glioma. Preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of neuroectodermal brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro killing of human glioblastoma by interleukin-2-activated autologous lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy with autologous white cell infusions (“lymphocytes”) in the treatment of recurrent glioblastoma multiforme.A preliminary report

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2702675

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00706746

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 July 2018

http://europepmc.org/abstract/MED/2702675

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q55485571&oldid=1381101282"